BBIBP‐CorV – Sinopharm‐Beijing vs placebo
Systemic reactogenicity events
BBIBP‐CorV – Sinopharm‐Beijing showed no clear difference in systemic reactogenicity eventse compared with placebo (moderate certainty).
1 finding from 1 review
- RR 1.05 [0.86, 1.28]3 studies · 27540 participantsModerate